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Hand, Foot and Mouth Disease (HFMD), a contagious viral disease that commonly affects infants and children with
blisters and flu like symptoms, is caused by a group of enteroviruses such as Enterovirus 71 (EV71) and
coxsackievirus A16 (CA16). However some HFMD caused by EV71 may further develop into severe neurological
complications such as encephalitis and meningitis. The route of transmission was postulated that the virus transmit
from one person to another through direct contact of vesicular fluid or droplet from the infected or via faecal-oral
route. To this end, this study utilised a human colorectal adenocarcinoma cell line (HT29) with epithelioid
morphology as an in vitro model for the investigation of EV71 replication kinetics. Using qPCR, viral RNA was first
detected in HT29 cells as early as 12 h post infection (hpi) while viral protein was first detected at 48 hpi. A
significant change in HT29 cells’ morphology was also observed after 48 hpi. Furthermore HT29 cell viability also
significantly decreased at 72 hpi. Together, data from this study demonstrated that co-culture of HT29 with EV71 is
a useful in vitro model to study the pathogenesis of EV71.
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Hand, Foot and Mouth Disease (HFMD), a contagious
viral disease that commonly affects infants and children,
are caused by a group of enteroviruses such as Entero-
virus 71 (EV71) and coxsackievirus A16 (CA16) (Brown
et al. 1999; Cardosa et al. 2003; Lee et al. 2009; Prager
et al. 2003). This self-limiting disease is characterised by
fever, rashes, poor appetite and multiple ulcers in mouth
(Brown et al. 1999; Cardosa et al. 2003; Lee et al. 2009;
Prager et al. 2003). However, patients infected with
EV71 may further develop severe neurological complica-
tion such as aseptic meningitis and brainstem/cerebellar
encephalitis (Lee and Chang 2010; Lee et al. 2009; Singh
et al. 2002; Solomon et al. 2010; McMinn 2002).
EV71, a member from the Enterovirus genus of the
Picornaviridae family, is a non-enveloped, positive sense,
single stranded, RNA virus with genomic RNA of ap-
proximately 7400 bp in length (Lee and Chang 2010;* Correspondence: l.hafner@qut.edu.au
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HFMD patients with central nervous system disease in
1969 (Schmidt et al. 1974). Large fatal EV71 outbreaks
of HFMD first appeared in Bulgaria in 1975, and disease
outbreaks were subsequently identified in Hungary in
1978 and re-emerged in Malaysia in 1997 and Taiwan in
1998 (Chumakov et al. 1979; Nagy et al. 1982; Ho et al.
1999; Lu et al. 2002; Solomon et al. 2010). HFMD epi-
demics and pandemics have been periodically reported
worldwide with outbreaks occurring every two to three
years in countries including Australia, China, Taiwan,
Japan, Korea, Malaysia, Vietnam, Thailand and Singapore
(Schmidt et al. 1974; Chumakov et al. 1979; McMinn
et al. 2001; Huang et al. 2012). Although the consistent
presences and outbreaks of HFMD push for an urgent
need to develop a vaccine or antiviral therapies against
enteroviruses (Pourianfar et al. 2012; McMinn et al.
2001; Tan et al. 2007a,b; Tan et al. 2010). Currently,
there are no available antiviral therapies or vaccines ap-
proved by the United States Food and Drug Administra-
tion (FDA) to prevent HFMD infections (Li et al. 2007).
The route of transmission of EV71 was postulated to
happen via direct contact of vesicular fluid or dropletpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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2010; Lee et al. 2009; Liu et al. 2000; Brown et al. 1999).
EV71 was shown to replicate within the gastrointestinal
tract, bypass the gut barrier and infect into the skeletal
muscle cell before entering into the bloodstream and the
central nervous system (Wong et al. 2010; Lee et al.
2009; Liu et al. 2000; Brown et al. 1999). Indeed various
studies had shown in in vivo model such as mouse that
the intestine was the initial site of infection for EV71 in-
fection with the muscle cells responsible for persistent
infection supporting efficient virus replication (Chen
et al. 2007; Chen et al. 2004; Khong et al. 2012). There-
fore we hypothesised that it is relevant to study EV71
using an in vitro model of a human gastrointestinal cell
type origin during the initial stages of infection.
In this study, we used a human colorectal adenocar-
cinoma cell line (HT29) with epithelioid morphology as
an in vitro model for the investigation of EV71 replica-
tion kinetics. To characterise the virus replication in
HT29 cells, the viral VP1 RNA and protein were moni-
tored using qPCR and western blot respectively. In
addition, the cell viability of HT29 to EV71 infection
was monitored throughout the time course of 72 hours
posts infection (hpi).
Results
This study aims to characterise the viral replication in
an in vitro model of HFMD for EV71 pathogenesis
study. To this end a human colorectal adenocarcinoma
cell line (HT29) with epithelioid morphology was
infected with EV71 over the time course of 72 h.
Cytopathic effects and cell viability of HT29 cells during
EV71 infection
There are no changes between control and infected cells
at 12 hpi, 24 hpi and 48 hpi (Figure 1). However at
72 hpi there was a statistically significant decrease of
approximately 60% of the infected cells (17.6%) as com-
pared to control (77.5%). There are no apparent change
in morphology between infected and control cells at
12 hpi and 24 hpi. However, at 48 hpi and 72 hpi, cells
were observed to lose its adherence and round up which
suggest cells are under stress conditions (Figure 1) with
cytopathic effect observed. At 72 hpi, in comparison
with the control and infected cells, there was a higher
number of floating cells in the media which correlate to
the decrease in live cells count (Figure 1).
Viral kinetics of EV71 replication
To further study EV71 replication kinetics in HT29 cells,
the viral RNA and protein synthesis was monitored over
72 h. Using established protocols, the kinetics of EV71
RNA synthesis in infected HT29 cells were examined
quantitatively using qPCR at various time points (12 hr,24 hr, 48 hr and 72 hr) (Tan et al. 2008b). Control cells
show no viral RNA presents (Figure 2). There was an
expected exponential increase in viral RNA copy number
of the infected cells as measured by qPCR. Viral RNA
was first detected at 12 hpi. Approximately 5 million
virus copy number was detected at 12 hpi, which then
doubles at 24 hpi to approximately 10 million virus copy
number. Subsequently at 48 hpi, it increases 20 folds to
approximately 200 million virus copy number. Finally at
72 hpi, it increases 5 folds to 1000 million virus copy
number. The viral copy number quantitated had expo-
nential increase at every time points except 72 hpi where
there was only 5 folds increase in virus copy number
(Figure 2).
Viral kinetics of EV71 VP1 protein synthesis
In addition to the detection of viral RNA, the kinetics of
EV71 VP1 protein synthesis in infected HT29 cells was
monitored using western blot specific to EV71 (Figure 3).
Relative expression of EV71 VP1 protein of infected and
control cells were analysed using Image J and statistical
significant amount of virus protein were only detected at
48 hpi and 72 hpi.
Cellular receptor SCARB2 is present in both HT29 and RD
cells
Receptor binding is an essential and vital process during
virus infection of the cells (Patel and Bergelson 2009;
Yamayoshi et al. 2012). Cellular receptor plays an im-
portant role in the pathogenicity of viruses particularly
during the internalisation of virus during infection. As
such we quantified the relative expression of a functional
receptor, Scavenger receptor class B, member 2
(SCARB2) based on the formula: 2(Ct of gene−Ct of ACT).
Primers for SCARB2 and ACT were designed to span
exon-exon boundaries to give a single PCR product of
89 bp and 198 bp respectively (Figure 4). HT29 was
found to express SCARB2 at the expression level of ap-
proximately 20.2 as compared with RD cells of approxi-
mately 26.9. The presence of SCARB2 in HT29 further
supports HT29 cells as a viable in vitro model to study
EV71 pathogenesis.
Discussion
Viral replication kinetics plays an important role in the
understanding of virus pathogenesis (Baccam et al. 2006;
Chang et al. 2006; Major et al. 2004). The kinetics of
various viruses such as hepatitis C, Nipah virus and in-
fluenza virus have been reported in various studies and
have provided valuable information particularly in re-
sponse to antiviral therapeutics which aid in the under-
standing the host pathogen interaction (Baccam et al.
2006; Chang et al. 2006; Major et al. 2004). In compa-
rison, the only information reported for EV71 virus
Figure 1 Cell viability of HT29 cells following EV71 infection. Confluent HT29 cells were infected with or without EV71 (MOI of 1). (A) HT29
cell harvested at different time points and cell viability assessed using vital dye trypan blue. (n = 3, * = p values of < 0.05) (B) Micrograph of
confluent HT29 cell cultures were taken at a magnification of 20× at different time points for 72 h.
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proliferation in rhabdomyosarcoma (RD) cells, of muscle
cells origin as an in vitro model (Lu et al. 2011). In a
clinical context, this may not be a good representative
model during EV71 infection of a human host. Various
studies have demonstrated in animal model that the
gastrointestinal tract such as the intestine was the first
site for EV71 proliferation (Chen et al. 2007; Chen et al.
2004; Khong et al. 2012). Furthermore, Khong et al.(2012) reported that mice that were administrated with
EV71 via the intraperitoneal route exhibits 100% morta-
lity as compared to mice that were administrated with
EV71 via the oral route which shows 10-30% mortality
(Khong et al. 2012). Interestingly, the mortality result of
mice administrated with EV71 via the oral route (gastro-
intestinal tract) reported by Khong et al. (2012)
corresponded to the percentage of EV71 infected human
patient with central nervous system complications. This
Figure 3 Kinetics of EV71 VP1 protein synthesis in HT29 cells. Conflue
intracellular protein were harvested at various time points and measured by w
of < 0.05) The results were then analysed using Image J. As observed, it trend
VP1 measured by Western blotting with Ponceau S staining control of memb
Figure 2 Kinetics of EV71 replication in HT29 cells. Confluent
HT29 cells were infected with or without EV71 (MOI of 1). Total
intracellular RNA were harvested at various time points, converted to
cDNA and measured by quantitative real time polymerase chain reaction
(qRT-PCR) with primers specific to viral VP1. (n = 3, * = p values of < 0.05)
As observed, there was an increase in viral copy number through
increasingly time points.
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line (oral route), HT29 as an in vitro model (Ooi et al.
2010; Ooi et al. 2009; Ooi et al. 2007).
In this study, we have demonstrated that upon EV71
infection in human epithelial colorectal cell line (HT29),
significant cell death only occurs at 72 hpi. This was var-
ies from the rhabdomyosarcoma (RD) cells previously
reported by Lu et al. (2011) where most cell death
occurs within 24 hpi. Similarly Chen et al. (2007) and
Khong et al. (2012) proposed that skeletal muscle cells
such as RD cells are more effective in supporting viral
replication which allow persistent enterovirus infection
to represent viral source of entry into the central ner-
vous system (CNS) (Chen et al. 2007; Khong et al. 2012).
In comparison with EV71 RNA synthesis, RNA was first
detected at 12 hpi. Viral protein synthesis was only ob-
served at a later stage during the infection possibly due
to translational time required. Lu et al. (2011) showed a
similar trend that virus RNA was first detected at 3 hpi
while virus protein was observed at 6 hpi. We reckonnt HT29 cells were infected with or without EV71 (MOI of 1). Total
estern blot captured using Quantity One software. (n = 3, * = p values
s the results we observed by viral RNA amplification. (A) Intracellular viral
rane (B) Relative expression of viral VP1 protein.
Figure 4 Expression SCARB2 in RD and HT29 cells. Total intracellular RNA were harvested from RD and HT29 cells, converted to cDNA and
measured by quantitative real time polymerase chain reaction (qRT-PCR) with primers specific to SCARB2 and ACT. Primers for SCARB2 and ACT
were designed to span exon-exon boundaries to give a single PCR product of 89 bp and 198 bp respectively. The presence of SCARB2 in HT29
further supports HT29 cells as a viable in vitro model to study EV71 pathogenesis.
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takes three times longer for the virus to kill HT29 cells
in comparison with RD cells Additional file 1: Table S1.
Receptor binding is an essential and vital process dur-
ing virus infection of the cells (Patel and Bergelson 2009;
Tan et al. 2013; Yamayoshi et al. 2012). Cellular recep-
tors therefore play an important role in the pathogen-
icity of viruses. Notwithstanding, viruses have been
found to utilise multiple receptors for the facilitation of
entry into susceptible cells (Patel and Bergelson 2009;
Hayes et al. 2006; Yamayoshi et al. 2009). Thus the iden-
tification and characterisation of cellular receptors plays
a critical role in the understanding of EV71 pathogen-
esis. Scavenger receptor class B, member 2 (SCARB2)
was first reported by Yamayoshi et al. (2009) to be a re-
ceptor for all EV71 strains and expressed in the sites of
EV71 replication in vivo (Hayes et al. 2006; Yamayoshi
et al. 2009). It is composed of 478 amino acids and
belongs to the CD36 family (Yamayoshi et al. 2012).
SCARB2 is commonly found in abundant in the lyso-
somal membrane of the cell and assist in the internalisa-
tion of EV71 into the host cell via clathrin mediated
endocytosis (Hussain et al. 2011; Lui et al. 2013;
Yamayoshi et al. 2012). The presence of SCARB2 inHT29 further supports HT29 cells as a viable in vitro
model to study EV71 pathogenesis.
Considering that different cell types have varying cel-
lular content such as cytoskeleton and endoplasmic
reticulum network which would potentially plays a role
in virus replication, it is therefore the virus replication
kinetics may differs from cell types to cell types. Indeed,
Hussain et al. (2011) has demonstrated that the cytoskel-
etal system comprising of both actin and microtubules
were involved endocytic kinetics (Buss et al. 2001;
Durrbach et al. 1996; Flanagan and Lin 1980; Hussain
et al. 2011). The knockdown of genes involves in
cytoskeleton formation such as ARPC5, ARRB1, and
WASF1 and the use of drug disrupting the cytoskeleton
network such as cytochalasin B, have resulted in the de-
crease in EV71 replication kinetics (Hussain et al. 2011;
Lui et al. 2013).
Furthermore, the incubation period for HFMD is be-
tween three to seven days (Khong et al. 2012; Ooi et al.
2010; Ooi et al. 2009; Ooi et al. 2007). This may corres-
pond to the number of days the virus requires to pass
through the gastrointestinal tract before spreading it
throughout the body Khong et al. 2012; Ooi et al. 2010;
Ooi et al. 2009; Ooi et al. 2007). Therefore the in vitro
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and EV71 may be more clinically relevant and mimics
the mechanism of pathogenesis of EV71 closer.
Conclusions
In conclusion, we have established the use of HT29 cells
as a clinically relevant in vitro model of EV71 repli-
cation. We have demonstrated for the first time an
increase of viral concentration in a time course of
72 hours upon infection with the use of cell viability,
qPCR and western blot. In addition, this is the first
report on the presence of SCARB2 on HT29 cells, an
essential receptor for all EV71 strains which established
HT29 cells as a viable in vitro model to study EV71
pathogenesis. Our study has provide valuable knowledge
toward the study of EV71 pathogenesis, virus-host inter-
action and this could lead to future investigation for the
development of antiviral therapeutics against EV71.
Therapeutic agents against EV71 could be developed by
potentially inhibit several key stages of the viral life cycle
such as viral attachment, translation, polyprotein pro-
cessing and RNA replication with the use of HT29 as an
in vitro model for EV71 replication (Chen et al. 2008).
Methods
Cell culture and virus propagation
Human colorectal cell line (HT29) (ATCCW catalog no.
HTB-38™) was maintained in Roswell Park Memorial In-
stitute medium (RPMI) (PAA Laboratories, Austria)
supplemented with 10% (v/v) Fetal Bovine Serum (FBS)
(PAA Laboratories, Austria) and 2% penicillin–strepto-
mycin (PAA Laboratories, Austria) at 37°C with 5% CO2.
The EV71 strain used in this study was isolated from a
fatal case of HFMD during October 2000 outbreak in
Singapore, Enterovirus 5865/sin/000009 strain (accession
number 316321; hereby designated as Strain 41) from
subgenogroup B4. The virus stock was prepared by
propagation of viruses using 90% confluent HT29 cells
monolayer in RPMI with 10% FBS and 2% penicillin–
streptomycin at 37°C with 5% CO2. The virus titres were
determined using 50% tissue culture infective dose
(TCID50) per millilitre (mL) according to Reed and
Muench method (Reed and Muench 1938).
Viral infection
HT29 cells were seeded at a concentration of 2 × 106 cells/ml
in 6-well plates and incubated for 24 h at 37°C with 5%
CO2. Cells were washed twice with phosphate buffered sa-
line (PBS) and infect with EV71 at multiplicity of infection
(MOI) of 1 or nil respectively. Following infection for 1 h,
the culture media were removed and replaced with 2 mL
of fresh RPMI medium. Micrograph was then taken using
phase contrast microscopy at different time points after
which the cells were trypsinised and harvested at 12 h,24 h, 48 h and 72 h to isolate RNA and proteins for qPCR
reactions and western blots respectively.
Cell viability and counts
Cell count and viability was performed on the Luna™
Automated Cell Counter system (Logos Biosystem,
USA) in accordance to the manufacturer’s instructions.
Briefly, the cells were trypsinised at different time points
(12 h, 24 h, 48 h and 72 h). The trypsinised cells were
then topped up with fresh media to a total volume of
1000 μl of media and 10 μl of this cell suspension were
mixed with 10 μl of tryphan blue. 10 μl of this diluted
cell suspension were then loaded onto the Luna™
counting slide for analysis.
RNA isolation and cDNA synthesis
The total cellular RNA of HT29 cells were extracted
using the miRNeasy mini kit (Qiagen, Hilden, Germany)
in accordance to the manufacturer’s instructions. Briefly,
the cells were lysed and homogenise using lyses solution
provided (Qiagen, Hilden, Germany). Total RNA were
harvested using the RNeasy spin column and wash twice
before elution (Qiagen, Hilden, Germany). Harvested
total RNA was quantitated using Nanodrop 100 spectro-
photometer (Thermo Scientific, Waltham, USA) and
1 ng of the total RNA was then reverse transcripted
using the iScript™ cDNA Synthesis Kit (Bio-Rad Labora-
tories, CA, USA) in accordance to the manufacturer’s in-
structions. Briefly, 1 ng of the extracted RNA was mixed
with enzyme reverse transcriptase and buffer to a vol-
ume of 20 ul and subjected to thermal profile of 25°C
for 5 m, 42°C for 30 m followed by 85°C for 5 m in ac-
cordance to the manufacturer’s instructions.
Quantitative real time polymerase chain reaction
The EV71 specific primers targeting the conserve VP1
regions were 5′-GCTCTATAGGAGATAGTGTGAGTA
GGG-3′ and the reverse primer 5′-ATGACTGCTCAC
CTGCGTGTT-3′ (Tan et al. 2008a). Primers for
SCARB2 receptors were 5′- CCAATACGTCAGACAAT
GCC-3′ and the reverse primer 5′-ACCATTCTTGCA
GATGCTGA-3′ were designed to span exon-exon
boundaries. The primers for the house keeping gene
actin (ACT) used were 5′- ACCAACTGGGACGACAT
GGAGAAA-3′ and the reverse primer 5′-TAGCA
CAGCCTGGATAGCAACGTA-3′. The quantitative real
time polymerase chain reaction (qRT-PCR) was per-
formed using the iQ™ SYBRW Green Super mix (Bio-Rad
Laboratories, CA, USA) on the Bio-Rad CFX96™ Real-
Time PCR system (Bio-Rad Laboratories, CA, USA).
Briefly, 1 μl of cDNA and 1 μl of the forward and the re-
verse primers were added to iQ™ SYBRW Green Super
mix. The reaction mix was then subjected to thermal
profile of denaturation at 95°C for 10 m, followed by
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10 s, 60°C for 30 s followed by 50°C for 30 s. At the end of
amplification cycles, melting temperature analysis was
performed by the Bio-Rad CFX96™ Real-Time PCR system
(Bio-Rad Laboratories, CA, USA). Relative gene expression
was quantified based on the formula: 2(Ct of gene−Ct of ACT).
Western blot
Total cellular protein extraction for HT29 cells and con-
trol cells were performed using a lysis mix in mamma-
lian cell lysis solution – CelLytic M (Sigma-Aldrich Pte
Ltd, USA) in accordance with manufacturer’s instruc-
tions. Equal protein concentration (20 μg) from each
samples were added into SDS PAGE, 10% Mini-
PROTEANW TGX™ (Bio-Rad Laboratories, CA, USA)
and separated by electrophoresis. Separated proteins
were transferred onto polyvinylidene diflouride mem-
branes (Invitrogen, California, USA) using iBlotW
Western Detection kit (Invitrogen, California, USA) in
accordance to manufacturer instructions. Ponceau S
staining was performed to ensure equal level of protein
present in all lanes according to Romero-Calvo et al.
(2010) (Romero-Calvo et al. 2010). Briefly, membranes
were stained with Ponceau S (Sigma-Aldrich Pte Ltd,
USA) for 1 m and washed three times with water to
remove stain. Western blot was then performed
using Western BreezeW Chromogenic Kit–Anti-Mouse
(Invitrogen, California, USA) in accordance to manufac-
turer instructions. Briefly, the membranes were incu-
bated with mouse anti EV71 antibody (AbD serotech,
Oxford, UK) or anti Tubulin antibody (Santa Cruz
Biotechnology inc, California, USA) respectively in
shaker for an hour. The membranes were washed three
times before and incubating with secondary antibodies
(Invitrogen, California, USA) for 30 m. The membranes
were washed three times and incubated with chromogen
substrate till purple bands were developed in 1 h. The
membranes were left to air dry then placed into the
densitometer and scanned using the Quantity One soft-
ware (Bio-Rad Laboratories, CA, USA). The picture
was analysed using Image J (National Institutes of
Health, USA).
Statistical analysis
All statistical analysis was performed on Graph Pad
Prism Version 6.0c (Graph Pad Software, USA). Student
t test was used to compare two groups. p values of < 0.05
were considered statistically significant.Additional file
Additional file 1: Table S1. Proposed timeline of EV71 replication
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